106 related articles for article (PubMed ID: 14506157)
1. Aberrant methylation of the HIC1 promoter is a frequent event in specific pediatric neoplasms.
Rathi A; Virmani AK; Harada K; Timmons CF; Miyajima K; Hay RJ; Mastrangelo D; Maitra A; Tomlinson GE; Gazdar AF
Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3674-8. PubMed ID: 14506157
[TBL] [Abstract][Full Text] [Related]
2. Aberrant promoter methylation and silencing of the RASSF1A gene in pediatric tumors and cell lines.
Harada K; Toyooka S; Maitra A; Maruyama R; Toyooka KO; Timmons CF; Tomlinson GE; Mastrangelo D; Hay RJ; Minna JD; Gazdar AF
Oncogene; 2002 Jun; 21(27):4345-9. PubMed ID: 12082624
[TBL] [Abstract][Full Text] [Related]
3. Aberrant promoter methylation and silencing of laminin-5-encoding genes in breast carcinoma.
Sathyanarayana UG; Padar A; Huang CX; Suzuki M; Shigematsu H; Bekele BN; Gazdar AF
Clin Cancer Res; 2003 Dec; 9(17):6389-94. PubMed ID: 14695139
[TBL] [Abstract][Full Text] [Related]
4. Identification of the p53 family-responsive element in the promoter region of the tumor suppressor gene hypermethylated in cancer 1.
Britschgi C; Rizzi M; Grob TJ; Tschan MP; Hügli B; Reddy VA; Andres AC; Torbett BE; Tobler A; Fey MF
Oncogene; 2006 Mar; 25(14):2030-9. PubMed ID: 16301995
[TBL] [Abstract][Full Text] [Related]
5. Methylation-associated silencing of death-associated protein kinase gene in laryngeal squamous cell cancer.
Kong WJ; Zhang S; Guo C; Zhang S; Wang Y; Zhang D
Laryngoscope; 2005 Aug; 115(8):1395-401. PubMed ID: 16094112
[TBL] [Abstract][Full Text] [Related]
6. HIC1 promoter methylation and 17p13.3 allelic loss in invasive ductal carcinoma of the breast.
Parrella P; Scintu M; Prencipe M; Poeta ML; Gallo AP; Rabitti C; Rinaldi M; Tommasi S; Paradiso A; Schittulli F; Valori VM; Toma S; Altomare V; Fazio VM
Cancer Lett; 2005 May; 222(1):75-81. PubMed ID: 15837543
[TBL] [Abstract][Full Text] [Related]
7. Promoter methylation as a common mechanism for inactivating E-cadherin in human salivary gland adenoid cystic carcinoma.
Zhang CY; Mao L; Li L; Tian Z; Zhou XJ; Zhang ZY; Li J
Cancer; 2007 Jul; 110(1):87-95. PubMed ID: 17520682
[TBL] [Abstract][Full Text] [Related]
8. Biallelic methylation and silencing of paternally expressed gene 3 (PEG3) in gynecologic cancer cell lines.
Dowdy SC; Gostout BS; Shridhar V; Wu X; Smith DI; Podratz KC; Jiang SW
Gynecol Oncol; 2005 Oct; 99(1):126-34. PubMed ID: 16023706
[TBL] [Abstract][Full Text] [Related]
9. Hypermethylation of the GATA genes in lung cancer.
Guo M; Akiyama Y; House MG; Hooker CM; Heath E; Gabrielson E; Yang SC; Han Y; Baylin SB; Herman JG; Brock MV
Clin Cancer Res; 2004 Dec; 10(23):7917-24. PubMed ID: 15585625
[TBL] [Abstract][Full Text] [Related]
10. The tumor suppressor gene hypermethylated in cancer 1 is transcriptionally regulated by E2F1.
Jenal M; Trinh E; Britschgi C; Britschgi A; Roh V; Vorburger SA; Tobler A; Leprince D; Fey MF; Helin K; Tschan MP
Mol Cancer Res; 2009 Jun; 7(6):916-22. PubMed ID: 19491197
[TBL] [Abstract][Full Text] [Related]
11. DNA methylation of genes linked with retinoid signaling in gastric carcinoma: expression of the retinoid acid receptor beta, cellular retinol-binding protein 1, and tazarotene-induced gene 1 genes is associated with DNA methylation.
Shutoh M; Oue N; Aung PP; Noguchi T; Kuraoka K; Nakayama H; Kawahara K; Yasui W
Cancer; 2005 Oct; 104(8):1609-19. PubMed ID: 16134180
[TBL] [Abstract][Full Text] [Related]
12. The correlation between aberrant connexin 43 mRNA expression induced by promoter methylation and nodal micrometastasis in non-small cell lung cancer.
Chen JT; Cheng YW; Chou MC; Sen-Lin T; Lai WW; Ho WL; Lee H
Clin Cancer Res; 2003 Sep; 9(11):4200-4. PubMed ID: 14519646
[TBL] [Abstract][Full Text] [Related]
13. HIC1 hypermethylation is a late event in hematopoietic neoplasms.
Issa JP; Zehnbauer BA; Kaufmann SH; Biel MA; Baylin SB
Cancer Res; 1997 May; 57(9):1678-81. PubMed ID: 9135007
[TBL] [Abstract][Full Text] [Related]
14. Promoter methylation of the secreted frizzled-related protein 1 gene SFRP1 is frequent in hepatocellular carcinoma.
Shih YL; Shyu RY; Hsieh CB; Lai HC; Liu KY; Chu TY; Lin YW
Cancer; 2006 Aug; 107(3):579-90. PubMed ID: 16795071
[TBL] [Abstract][Full Text] [Related]
15. Frequent aberrant methylation of the CDH4 gene promoter in human colorectal and gastric cancer.
Miotto E; Sabbioni S; Veronese A; Calin GA; Gullini S; Liboni A; Gramantieri L; Bolondi L; Ferrazzi E; Gafà R; Lanza G; Negrini M
Cancer Res; 2004 Nov; 64(22):8156-9. PubMed ID: 15548679
[TBL] [Abstract][Full Text] [Related]
16. Methylation profiles of sporadic ovarian tumors and nonmalignant ovaries from high-risk women.
Rathi A; Virmani AK; Schorge JO; Elias KJ; Maruyama R; Minna JD; Mok SC; Girard L; Fishman DA; Gazdar AF
Clin Cancer Res; 2002 Nov; 8(11):3324-31. PubMed ID: 12429618
[TBL] [Abstract][Full Text] [Related]
17. [Relationship between RAR-beta gene expression defect and its methylation].
Gao YP; Li M; Zhang YY; Wang H; He XH; Wang ZH
Zhonghua Fu Chan Ke Za Zhi; 2007 Jul; 42(7):472-6. PubMed ID: 17961338
[TBL] [Abstract][Full Text] [Related]
18. LSAMP, a novel candidate tumor suppressor gene in human osteosarcomas, identified by array comparative genomic hybridization.
Kresse SH; Ohnstad HO; Paulsen EB; Bjerkehagen B; Szuhai K; Serra M; Schaefer KL; Myklebost O; Meza-Zepeda LA
Genes Chromosomes Cancer; 2009 Aug; 48(8):679-93. PubMed ID: 19441093
[TBL] [Abstract][Full Text] [Related]
19. Heterozygous disruption of Hic1 predisposes mice to a gender-dependent spectrum of malignant tumors.
Chen WY; Zeng X; Carter MG; Morrell CN; Chiu Yen RW; Esteller M; Watkins DN; Herman JG; Mankowski JL; Baylin SB
Nat Genet; 2003 Feb; 33(2):197-202. PubMed ID: 12539045
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic inactivation of ID4 in colorectal carcinomas correlates with poor differentiation and unfavorable prognosis.
Umetani N; Takeuchi H; Fujimoto A; Shinozaki M; Bilchik AJ; Hoon DS
Clin Cancer Res; 2004 Nov; 10(22):7475-83. PubMed ID: 15569977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
